Pharmaceutical leader Bristol-Myers Squibb announced earlier today the opening of a children’s clinical center at Robert Wood Johnson University Hospital, which will focus on researching and treating immune disorders afflicting children—including those living with HIV.
Of the 40 million people living with HIV across the globe, 2.3 million are under the age of 15. There are around 10,000 children living with the virus in the United States alone.
The Bristol-Myers Squibb Pediatric Infectious Disease and Immunology Center—along with two other clinics at the New Jersey hospital—was made possible through a $5 million donation from the Bristol-Myers Squibb Foundation.
“At Bristol-Myers Squibb, we believe that together we can prevail over serious illness,” says Jill DeSimone, vice president of BMS’s U.S. Virology division. “We are committed as a company in the battle against HIV and AIDS here in our community and throughout the world, and we stand united with others who are working to improve the lives of children and all people afflicted with this debilitating disease.”
NEW! Scroll down to comment on this story.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
laxoflove
